Sirona Biochem Corp. ('Sirona') announced that it has signed an agreement with Contract Manufacturing Organization (CMO) WuXi AppTec ('WuXi'), Shanghai, to launch large-scale production of TFC-1067, a novel skin dark spot remover, for global commercialization. WuXi has spent four months developing their manufacturing process for commercial grade TFC-1067. This process was recently completed, resulting in a highly pure production of TFC-1067 with the ability to scale to any quantity needed by Sirona. Sirona anticipates the need for multi-kilogram production of TFC-1067 through the remainder of 2020 with sustained large-scale quantities for commercialization required in 2021. To prevent gaps in manufacturing, and minimize risk, the compound will be produced in multiple locations. Roowin, the current CMO in France, will remain a producer in addition WuXi. Given the high potency of TFC-1067, each kilogram of Sirona's active ingredient will produce up to ten thousand consumer size (fifty milliliters) containers of finished product.